Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

61.

Clonal fate mapping quantifies the number of haematopoietic stem cells that arise during development.

Nat. Cell Biol.
Henninger J, Santoso B, Hans S, Durand E, Moore J, Mosimann C, Brand M, Traver D, Zon L.
| 11 21, 2016
62.

Inactivation of Capicua drives cancer metastasis.

Nat. Genet.
Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A, Blakely CM, Haringsma HJ, Simmons AD, Gowen K, Suh J, Miller VA, Ali S, Schuler M, Bivona TG.
| 11 21, 2016
63.

Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias.

Nat. Genet.
Dunford A, Weinstock DM, Savova V, Schumacher SE, Cleary JP, Yoda A, Sullivan TJ, Hess JM, Gimelbrant AA, Beroukhim R, Lawrence MS, Getz G, Lane AA.
| 11 21, 2016
64.

Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.

Cell.
Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RG, DePinho RA.
| Nov 17, 2016
65.

PKM2, cancer metabolism, and the road ahead.

EMBO Rep.
Dayton TL, Jacks T, Vander Heiden MG.
| 11 17, 2016
66.

Dynamic metabolic exchange governs a marine algal-bacterial interaction.

Elife.
Segev E, Wyche TP, Kim KH, Petersen J, Ellebrandt C, Vlamakis H, Barteneva N, Paulson JN, Chai L, Clardy J, Kolter R.
| Nov 18, 2016
67.

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Proc. Natl. Acad. Sci. U.S.A.
Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, Livingston DM.
| Nov 29, 2016
68.

Gut microbiota induce IGF-1 and promote bone formation and growth.

Proc. Natl. Acad. Sci. U.S.A.
Yan J, Herzog JW, Tsang K, Brennan CA, Bower MA, Garrett WS, Sartor BR, Aliprantis AO, Charles JF.
| Nov 22, 2016
69.

Quantifying the evolution of individual scientific impact.

Science.
Sinatra R, Wang D, Deville P, Song C, Barabási AL.
| Nov 04, 2016
70.

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.

Nature.
Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, Fisher JM, Rodman C, Mount C, Filbin MG, Neftel C, Desai N, Nyman J, Izar B, Luo CC, Francis JM, Patel AA, Onozato ML, Riggi N, Livak KJ, Gennert D, Satija R, Nahed BV, Curry WT, Martuza RL, Mylvaganam R, Iafrate AJ, Frosch MP, Golub TR, Rivera MN, Getz G, Rozenblatt-Rosen O, Cahill DP, Monje M, Bernstein BE, Louis DN, Regev A, Suvà ML.
| Nov 10, 2016
71.

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis.

Nature.
Kottakis F, Nicolay BN, Roumane A, Karnik R, Gu H, Nagle JM, Boukhali M, Hayward MC, Li YY, Chen T, Liesa M, Hammerman PS, Wong KK, Hayes DN, Shirihai OS, Dyson NJ, Haas W, Meissner A, Bardeesy N.
| Nov 17, 2016
72.

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models.

Nature.
Cho H, Du X, Rizzi JP, Liberzon E, Chakraborty AA, Gao W, Carvo I, Signoretti S, Bruick RK, Josey JA, Wallace EM, Kaelin WG.
| Nov 03, 2016
73.

Role for the IFT-A Complex in Selective Transport to the Primary Cilium.

Cell Rep.
Fu W, Wang L, Kim S, Li J, Dynlacht BD.
| Nov 01, 2016
74.

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

N. Engl. J. Med.
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J.
| Nov 03, 2016
75.

Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor.

Proc. Natl. Acad. Sci. U.S.A.
Mathew G, Hannan A, Hertzler-Schaefer K, Wang F, Feng GS, Zhong J, Zhao JJ, Downward J, Zhang X.
| Nov 15, 2016
76.

Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma.

Proc. Natl. Acad. Sci. U.S.A.
Hideshima T, Qi J, Paranal RM, Tang W, Greenberg E, West N, Colling ME, Estiu G, Mazitschek R, Perry JA, Ohguchi H, Cottini F, Mimura N, Görgün G, Tai YT, Richardson PG, Carrasco RD, Wiest O, Schreiber SL, Anderson KC, Bradner JE.
| Nov 15, 2016
77.

Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.

Nat. Biotechnol.
Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P, Xu H, Xiao T, Cao Z, Peng J, Yuan P, Brown M, Liu XS, Wei W.
| 10 31, 2016
78.

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.

Nat. Biotechnol.
Stevens MM, Maire CL, Chou N, Murakami MA, Knoff DS, Kikuchi Y, Kimmerling RJ, Liu H, Haidar S, Calistri NL, Cermak N, Olcum S, Cordero NA, Idbaih A, Wen PY, Weinstock DM, Ligon KL, Manalis SR.
| 10 10, 2016
79.

Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.

Nat. Immunol.
Sage PT, Ron-Harel N, Juneja VR, Sen DR, Maleri S, Sungnak W, Kuchroo VK, Haining WN, Chevrier N, Haigis M, Sharpe AH.
| 10 03, 2016
80.

Modeling of RNA-seq fragment sequence bias reduces systematic errors in transcript abundance estimation.

Nat. Biotechnol.
Love MI, Hogenesch JB, Irizarry RA.
| 09 26, 2016